Cargando…

Long-acting versus short-acting granulocyte colony-stimulating factors among cancer patients after chemotherapy in China: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Granulocyte colony-stimulating factors (G-CSFs) include long-acting ones and short-acting ones. They have been mainly applied in Chinese clinical practice for years to prevent neutropenia. However, which type of G-CSF is more superior has not been conclusively determined. METHODS: A syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Genzhu, Zhang, Yonghe, Wang, Xiaoying, Sun, Qiang, Xun, Zhikun, Yuan, Minglu, Li, Zhongdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702283/ https://www.ncbi.nlm.nih.gov/pubmed/34941082 http://dx.doi.org/10.1097/MD.0000000000028218

Ejemplares similares

Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
por: Cornes, Paul, et al.
Publicado: (2018)

Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
por: Cornes, Paul, et al.
Publicado: (2018)

Granulocyte colony-stimulating factor acts on lymphoid-biased, short-term hematopoietic stem cells
por: Chen, Yulin, et al.
Publicado: (2021)

The association between 5, 10 – methylenetetrahydrofolate reductase and the risk of unexplained recurrent pregnancy loss in China: A Meta-analysis
por: Wang, Genzhu, et al.
Publicado: (2021)

Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic
por: Wei, Chong, et al.
Publicado: (2021)

Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature
por: Masuda, Yasutaka, et al.
Publicado: (2023)

Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
por: Arvedson, Tara, et al.
Publicado: (2015)

Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis
por: Chuang, Yu-Min, et al.
Publicado: (2020)

Granulocyte colony-stimulating factor directly acts on mouse lymphoid-biased but not myeloid-biased hematopoietic stem cells
por: Xie, Miner, et al.
Publicado: (2020)

Eflapegrastim, a Long‐Acting Granulocyte‐Colony Stimulating Factor for the Management of Chemotherapy‐Induced Neutropenia: Results of a Phase III Trial
por: Schwartzberg, Lee S., et al.
Publicado: (2020)

Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product
por: Mendelsohn, Aaron B., et al.
Publicado: (2021)

Granulocyte Colony-Stimulating Factor Activating HIF-1α Acts Synergistically with Erythropoietin to Promote Tissue Plasticity
por: Liu, Shih-Ping, et al.
Publicado: (2010)

STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
por: Zeng, Tao, et al.
Publicado: (2023)

CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma
por: Zhang, Jingxin, et al.
Publicado: (2022)

Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis
por: Bai, Long, et al.
Publicado: (2016)

Correction: Granulocyte Colony-Stimulating Factor Activating HIF-1α Acts Synergistically with Erythropoietin to Promote Tissue Plasticity
por: Liu, Shih-Ping, et al.
Publicado: (2010)

SIRT3 acts as a novel biomarker for the diagnosis of lung cancer: A retrospective study
por: Tao, Feng, et al.
Publicado: (2021)

Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma
por: Ding, Xinjing, et al.
Publicado: (2022)

Clinical characteristics and management of primary granulocytic sarcoma of the breast: A case report
por: Wu, Heng-yu, et al.
Publicado: (2019)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
por: Advani, S. H., et al.
Publicado: (2010)

Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
por: Shokane, Lucky L., et al.
Publicado: (2023)

Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
por: Ashrafi, Farzaneh, et al.
Publicado: (2018)

Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer: A systematic review and meta-analysis
por: Mo, Huaqing, et al.
Publicado: (2021)

Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer
por: Peng, Shu hui, et al.
Publicado: (2021)

Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004)

Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte
por: Chen, Liang, et al.
Publicado: (2016)

Treatment outcomes of induction chemotherapy combined with intensity-modulated radiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in Southeast China
por: Wang, Peirong, et al.
Publicado: (2021)

Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2020)

Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma: A SEER population-based study
por: Lu, Yan, et al.
Publicado: (2021)

Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011)

The Efficacy of Erlotinib Versus Conventional Chemotherapy for Advanced Nonsmall-Cell Lung Cancer: A PRISMA-Compliant Systematic Review With Meta-Regression and Meta-Analysis
por: Ma, Hu, et al.
Publicado: (2016)

Granulocyte Colony-Stimulating Factor in Amniotic Fluid
por: Raynor, B. Denise, et al.
Publicado: (1995)

The importance of the granulocyte-colony stimulating factor in oncology
por: CETEAN, SÎNZIANA, et al.
Publicado: (2015)

Granulocyte Colony-stimulating Factor-associated Aortitis
por: Nishioka, Hiroaki, et al.
Publicado: (2023)

Thrombin Stimulates Synthesis of Macrophage Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor by Human Proximal Tubular Epithelial Cells in Culture
por: Shimaya, Yuko, et al.
Publicado: (2012)

The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer: A meta-analysis
por: Chen, Qiang, et al.
Publicado: (2016)

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.
por: Fukuoka, M., et al.
Publicado: (1997)

Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
por: Gawade, Prasad L., et al.
Publicado: (2020)

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
por: Katano, Mitsuo, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_bl90me3g72oa8q9bcdhn4g83t5